EUROPEAN MEDICINES AGENCY SCI E N C E M E D I C I N E S H ealth. Public hearings. Guidance for participants
|
|
- Rosalind Manning
- 5 years ago
- Views:
Transcription
1 EUROPEAN MEDICINES AGENCY SCI E N C E M E D I C I N E S H ealth Public hearings Guidance for participants
2 Table of contents Introduction 1 About EMA public hearings 2 1. What is an EMA public hearing? 2 2. Who decides to hold a public hearing? 2 3. How does EMA decide the subject of a public hearing? 2 4. Who can attend a public hearing? 2 Arriving at the hearing What happens when I arrive? What do I do if I have been chosen to speak but am delayed? What should I do if a journalist wishes to speak with me at the hearing? What happens if there is an emergency when I am in the building? 9 Participating at the hearing 3 5. How will I know there is a hearing? 3 6. How can I join a hearing? 3 7. How do I apply to attend? 3 8. How will EMA choose who attends? 4 9. How will I know if I can attend? What other information should I give if I wish to attend as a speaker? How will EMA choose speakers? What if I have not been chosen to speak? What language will be used at the hearing? 5 Preparing for the hearing Where can I find the hearing agenda and list of speakers? If I have been chosen as a speaker, how long will I have to speak? Where can I look up technical terms and abbreviations? What should I take to the hearing? Are facilities available for people with disabilities? 6 During the hearing What are the rules for the hearing? How will the hearing run? What are the rules for those speaking at the hearing? Can I use my laptop at the hearing? Can observers speak at the hearing? 11 After the hearing What record will be available of the hearing? Can participants report on a public hearing? How will the hearing contribute to EMA s work? 12 Additional information How can I get more information about the hearing? What is the legal basis for holding a public hearing? How will the Agency handle my personal information? Can the hearing be cancelled or postponed? 13 Travelling to the hearing Where is the hearing held? How long does a hearing take? What are the travel arrangements? How can I get to the hearing at EMA offices? Can I use Canary Wharf station if I have mobility problems? Will my travel costs be covered? How can I join the hearing if I cannot attend in person? 8
3 Introduction This guidance gives practical information about how the public can participate at EMA s public hearings. Public hearings at EMA are set up by EMA s safety committee, the Pharmacovigilance Risk Assessment Committee (PRAC). The hearings: The basis for holding public hearings is outlined within the Rules of procedure on the organisation and conduct of public hearings at the PRAC. contribute to EMA s knowledge of how the public, particularly patients, perceive the use of certain medicines; help EMA understand the possible results of its recommendations on the safe use of medicines; present the public with another means to provide input into EMA s decision-making; help the public understand EMA s evaluation of a medicine s safety. 1
4 About EMA public hearings 1. What is an EMA public hearing? A public hearing is a way for EMA s safety committee, PRAC, to gain input and insights from the public. It supplements other well-established methods that EMA already uses for engaging with stakeholders. The hearings usually cover a specific concern or risk with a medicine or a group of medicines. By working directly with people affected by the medicine, EMA can increase its understanding of how a medicine is used and make sure that EMA s actions to manage risks are appropriate and practical. Those attending the hearings will be PRAC members, EMA staff and members of the public, including patients, healthcare professionals, pharmaceutical companies and the press. 3. How does EMA decide the subject of a public hearing? EMA s safety committee considers whether a public hearing can help with the review of a particular medicine. Using the Rules of procedure, the committee considers: the nature of the safety concern; if the public hearing will fit within the timetable set for the review; what the medicine is used for and alternatives for treatment; the impact that the review s outcome may have on those using the medicines; By following public hearings, participants will learn how EMA works and particularly how EMA aims to improve a medicine s benefits by minimising risks. Contribution from the public at hearings will inform PRAC s decision making. PRAC assessment reports will show how information from the hearings contributed to the overall evaluation of the medicine under consideration. 2. Who decides to hold a public hearing? It is EMA s safety committee, PRAC, that decides on holding a public hearing. The hearing can be held at the beginning of a review on a safety concern of a medicine or later when the evidence is being evaluated. Details of the discussion on holding a public hearing will be included in the PRAC s minutes, which are published on the Agency s website after each full meeting. the level of public interest in the subject. 4. Who can attend a public hearing? Anyone can apply to attend a public hearing. Indeed, we are keen to have wide representation from right across the EU. We will do our best to accommodate everybody, taking into account the space and time available to us. Those aged under 18 years who bring personal experience or knowledge about the subject of the hearing may attend, but they must come with their guardian. Children aged under 12 years are not allowed to attend the public hearing. Pharmaceutical companies with an interest in the subject can also apply to attend, and journalists covering the hearing may attend as observers. 2
5 Participating at the hearing 5. How will I know there is a hearing? We will announce an upcoming public hearing on EMA website at least six weeks before the hearing date. We will also send the information through our established network to EU organisations likely to be interested in the subject of the hearing. Be sure to apply before the deadline shown in the hearing announcement. The application form will ask: your full name (which should match your photographic identification, see Question 26); your contact information; The announcement will outline the subject of the hearing, together with questions the committee would like the public to address. The announcement will give the date, time and place of the hearing, the deadline for applying and say how people can apply to attend in person. the country you live in; your connection with the subject of the hearing (i.e. if you are a patient, a carer, a healthcare professional, an academic, a company representative, or a journalist); 6. How can I join a hearing? if you wish to attend as an observer or as a speaker; You can attend our hearing as a speaker or as an observer. You can also follow it on a live video broadcast on the Agency s website. You must fill in an online application form if you wish to attend in person. The form will ask if you wish to attend as an observer or as a speaker. Those invited to speak will be given time for a short oral presentation at the hearing. We can cover some travel expenses for speakers Question 24 gives more information. You don t need to apply to us if you intend to watch the video broadcast. The link will be available on our website on the day. 7. How do I apply to attend? details of how you would address the safety committee s questions if you wish to speak; if you need an interpreter if you wish to attend as a speaker and you do not speak English; the name of your organisation or company, if you are representing one; why you are interested in the subject of the hearing. Use the application form to tell us of any special needs you have and if an official registered carer would need to accompany you. The online application is simple to fill in and you can print it after you have completed it. To attend our public hearing, you need to apply on our website. We will include a link to the application form in the announcement about the hearing. 3
6 Participating at the hearing 8. How will EMA choose who attends? The number of people that can attend the hearing is limited by how many people the room can seat and the time available for the hearing. Therefore, we may need to select participants based on their connection to the subject of the hearing, their experience and where they live. For speakers, we will also look at how they intend to address the safety committee s questions (see also Question 11). We may also need to limit attendance of observers from each organisation or group so that the hearing includes the widest range of participants. The sooner observers apply the more chance they have of being selected to attend. 9. How will I know if I can attend? If you cannot attend in person, you can take part by teleconference but you must tell us this in your application. 11. How will EMA choose speakers? We will choose as many speakers as we can for the hearing. We will group all speakers by affiliation (e.g. patients, health professionals) and will ensure that each group is given an opportunity to speak. If there isn t enough time for all those who have applied, here is how we will manage the number of speakers: limit the number of speakers from each group or organisation; use information in the application to give priority to those who are most strongly connected with the subject or those who are likely to bring unique views; We will write to you soon after the application deadline to let you know whether or not you can attend. We will also tell you if you will be attending as an observer or as a speaker. 10. What other information should I give if I wish to attend as a speaker? If you wish to speak at the public hearing, you should say so in your application. You should outline what you wish to say and how this is relevant to EMA safety committee s questions (included in the hearing announcement). We aim to allow about 7 minutes for each speaker. encourage speakers from different groups such as patients, healthcare professionals and academics to team up with others in the group and so combine several views in one presentation; consider where the applicant lives to ensure widest EU representation. Pharmaceutical companies with an interest in the subject of the hearing may also speak within the time allocated to their group. 4
7 Participating at the hearing 12. What if I have not been chosen to speak? 13. What language will be used at the hearing? If you applied to speak, but were not selected, you can send us your written views on the questions in the announcement. Send this statement to EMA s safety committee before the public hearing (by writing to publichearings@ema.europa.eu). Written statements will feed into the review in the same way as the oral presentations at the hearing. Our public hearings are in English, the working language of EMA. We strongly encourage participants to use English during the hearing. As a speaker, if you cannot make your presentation in English you may speak in another official EU language and request interpretation into English as you speak. In this case, you must request an interpreter when you first apply. However, we cannot arrange interpretations from English to other languages. 5
8 Preparing for the hearing 14. Where can I find the hearing agenda and list of speakers? 17. What should I take to the hearing? We will publish the agenda for the hearing and a list of confirmed speakers on EMA website, together with the time given to each speaker, in advance of the hearing. When you arrive, you must show us your passport or official photographic identification to attend the hearing. The name you have registered with us must match the photographic identification. 15. If I have been chosen as a speaker, how long will I have to speak? We will tell you how long you have to speak. This will normally be around 7 minutes, but may vary depending on the number of speakers. When you speak, please keep to the subject of the hearing and to the questions in the hearing announcement. By keeping to the time you are given, those who speak after you will also be able present their views properly. In this way the committee will hear the widest possible range of views. You can only take a small handbag with you to the meeting room with only essential items (see also Question 33). 18. Are facilities available for people with disabilities? The Agency building is adapted for people with disabilities and is entirely wheelchair accessible. Please tell us before you arrive at the hearing if you have any disability that could make it difficult for you to leave the building in an emergency. Do also tell us if a carer will be coming with you and ensure that the carer has completed a separate application. Do bear in mind that for your oral presentation you will not be able to use any multimedia materials such as presentation software (e.g. PowerPoint) or video clips. 16. Where can I look up technical terms and abbreviations? We will do our best not to use unnecessary technical language and abbreviations during the hearing. However, if you come across anything you don t understand, then have a look at the following page on our website: jsp?curl=pages/document_library/landing/glossary. jsp&mid 6
9 Travelling to the hearing 19. Where is the hearing held? We will say where the public hearing will be held at the time of the announcement. We usually hold the hearings at EMA s offices. Information on how to reach the offices is given under How can I get to the hearing at the EMA offices? (Question 22 below). 20. How long does a hearing take? Meeting Support Service: mms-e@ema.europa.eu telephone: +44 (0) How can I get to the hearing at EMA offices? You can find our address, together with a map and information about travel to our offices on the following page on our website: We generally hold public hearings in the afternoon and they last about 3 hours. The public hearing announcement on EMA website will give the timings. jsp?curl=pages/about_us/general/general_ content_ jsp&mid=wc0b01ac058097a27b 21. What are the travel arrangements? Please don t make any travel arrangements until we have confirmed that there is a place for you. If we have invited you as an observer, you should arrange and pay for all your travel to the hearing and for any accommodation you need. If you are attending as a speaker then we will organise and cover the cost of the main part of your travel (see Question 24). We will send you an official invitation, which includes a link to an online form where you tell us your travel requirements. We do not generally cover accommodation costs, but if an overnight stay is absolutely necessary for health reasons then please let us know in advance and we will arrange your accommodation. We cannot reimburse you for any travel (or accommodation) that you book yourself. If you have any questions about the travel arrangements for speakers do please contact our Canary Wharf station is very close to our offices on 30 Churchill Place. This is the best station to use if you are travelling by public transport. You can travel to the station on the Jubilee (underground) line or on the Docklands Light Railway (DLR). These lines use different parts of the station so how you reach our offices will depend on which line you use. From the Jubilee line We suggest you take the East exit, which is closest to our offices. When you leave the station, turn left into Upper Bank Street, turn right at Canada Square and continue straight into Churchill Place. If you leave the station by the West exit, on leaving the station, turn right into Canada Place, turn left into The South Colonnade towards Canada Square and then continue straight into Churchill Place. From the Docklands Light Railway (DLR) Leave the station into South Colonnade, turn left towards Canada Square and continue straight into Churchill Place. 7
10 Travelling to the hearing 23. Can I use Canary Wharf station if I have mobility problems? Canary Wharf station has step-free access. 25. How can I join the hearing if I cannot attend in person? All public hearings are broadcast and you can view them live on EMA website. If you travel on the Jubilee (underground) line, then there is a lift (elevator) at both the East and West exits. The East exit is closer to our offices. To avoid any steps, we suggest you take the East exit to Upper Bank Street, cross to Montgomery Street and then take the lift (elevator) up to the footbridge that brings you to our offices. Speakers who cannot travel may take part by teleconference. After the hearing, you can view a recording of the hearing and read a summary of the conclusions on EMA website. If you arrive on the Docklands Light Railway (DLR), you can take a lift (elevator) from all platforms. 24. Will my travel costs be covered? We cannot pay any costs if you are attending as an observer. If you have been invited to speak, then we will arrange your travel by air or train between cities or main travel hubs but you have to cover all other costs such as local transportation (i.e. underground, bus, taxi) and meals. If you wish to stay overnight in London this will be at your own cost, unless we have agreed that an overnight stay is essential for health reasons. Speakers must book air and train tickets through EMA. You will receive information in your invitation on how to do this. See also Question 21. 8
11 Arriving at the hearing 26. What happens when I arrive? You should aim to arrive at the EMA offices at least 45 minutes before the public hearing. When you arrive, go to the reception desk. We will check your photographic identification, check that you are on our list for the hearing, and give you a building pass. Do make sure that the name you have registered with us matches your photographic identification. You will then go through an airport-style security screening and we will show you to a lounge to wait for the hearing. We can store your luggage in a special area on the ground floor. You can take only a small handbag and a small bottle of water to the hearing. You cannot take any electronic devices to the meeting room except your mobile phone, which should be switched off during the hearing. We will take you to the meeting room 15 minutes before the hearing starts. to read it, if there is time and this is feasible. Alternatively, your contribution will be shared with the Committee in writing. 28. What should I do if a journalist wishes to speak with me at the hearing? It is perfectly fine to speak to journalists if you wish to. However, journalists should preferably speak with you outside our building. This is because having the press in the building can interfere with our work and security arrangements. Also, the use of cameras can affect the privacy of our staff, visitors and other participants because of the chance of getting caught on a camera-shot unknowingly. 29. What happens if there is an emergency when I am in the building? Your building pass must be visible while you are in the building. You can go only to the meeting room for the hearing and the public areas around it (such as the toilets). 27. What do I do if I have been chosen to speak but am delayed? If you have been chosen to speak but you are delayed or you cannot attend, please contact us as soon as you can (Tel: +44 (0) or publichearings@ema.europa.eu). If you arrive late and would still like to speak, we will try our best to arrange for you to speak at a different time during the hearing. In the very unlikely event that we need to leave the building because of an emergency, we will tell you what to do. Please follow our staff s instructions. You should make sure you know where the emergency exits are so you can leave the building quickly in an emergency. All emergency exits are signposted and they will also be pointed out to you at the beginning of the hearing. If you need help because of disability, tell us in advance and we will put you in touch with a buddy to help you in case there is an emergency. If you cannot attend, send us a speaker s statement and we may be able to arrange for a representative 9
12 During the hearing 30. What are the rules for the hearing? You should: follow the Chairperson s instructions during the meeting; switch off your mobile phone or set it to silent; respect the views and opinions of other speakers; report to us if anyone contacts you to try to influence the hearing discussions. You should not: disrupt or hinder the running of the hearing; take a laptop or a tablet computer to the meeting room; use audio- or video-recording or transmission devices, cameras and mobile phones during the hearing (which will be broadcast live and, afterwards, a recording of the hearing will be available on our website); distribute any documents or ask for documents to be circulated. 31. How will the hearing run? Public hearings are held during the monthly safety committee meetings, typically in the afternoon. The committee Chairperson will chair the hearing. safety concerns and outline the questions that are the focus of the hearing. The Chairperson will then invite presentations from speakers. The speakers will have been informed of the order in which they will speak and how long they will have. This information is also shown in the agenda. Once all the speakers have made their presentation, the Chairperson will summarise the presentations and explain the next steps of the review. If time permits, the Chairperson may invite participants (including observers) to make additional points about the presentations during the hearing. When the public hearing ends we will lead all participants back to the reception area where they can collect their belongings and return their passes before leaving the building. 32. What are the rules for those speaking at the hearing? Each speaker will speak from the podium into a microphone. The speakers should briefly introduce themselves and say if they are representing any organisation or group. They also need to mention any potential conflicts of interest they may have in connection with the subject of the hearing (we will give information to speakers on what should be declared). Speakers should keep to the time they have been given. We will time each speaker with a visible timer in the room so you will know how much time you have left. The Chairperson will begin the hearing with opening comments. We will also give you some general information about the hearing. The main assessors involved in the scientific evaluation will set out the If the time given to the speaker is about to end and the speaker has not started concluding the presentation, the Chairperson will ask the speaker to end the presentation with final remarks. If the 10
13 During the hearing speaker does not end the presentation after being asked to do so, we may turn off the speaker s microphone. The Chairperson may also interrupt the speaker if the speaker deviates from the subject of the hearing. At the end of a presentation, committee members may ask questions or ask the speaker to clarify certain points. 34. Can observers speak at the hearing? Observers should not speak during a public hearing. However, if there is time at the end of a hearing, the Chairperson may invite anyone in the room to speak briefly on the subject of the hearing and on the questions in the announcement. 33. Can I use my laptop at the hearing? You cannot take any electronic equipment to the public hearing except your mobile phone, which must be switched off or set to silent during the hearing. All other electronic equipment should be stored with your personal luggage in the reception area lounge. Personal recording of the public hearing is not permitted because of data protection regulations (see also Question 40). 11
14 After the hearing 35. What record will be available of the hearing? 37. How will the hearing contribute to EMA s work? A recording of the meeting, the list of all speakers, including their connection with the subject of the hearing, and any declared interests as well as a summary of the conclusions of the meeting will be published on EMA website. 36. Can participants report on a public hearing? EMA s safety committee will consider the contributions from the public hearing in its review of the subject of the hearing. The committee s assessment report, which is available to the public once the review is complete, will include information about the hearing and how the committee used its outcome. Those attending a public hearing, including the media, may report on the meeting, but they must not quote or identify individuals. They may quote or refer to the Chairperson s conclusions on summing up the discussion. 12
15 Additional information 38. How can I get more information about the hearing? 41. Can the hearing be cancelled or postponed? If you have any other questions or if you need more information, please ask us by sending an to: publichearings@ema.europa.eu 39. What is the legal basis for holding a public hearing? We may have to cancel a public hearing in case of unexpected circumstances. We will announce the cancellation as soon as we can but EMA cannot be held liable for any expenses incurred. If we cannot arrange another date for the public hearing, we will ask for written contributions. EMA s safety committee (Pharmacovigilance Risk Assessment Committee) calls a public hearing to help it consider certain matters about the safe use of medicines. These matters are brought to the committee through procedures set out in Article 20 of Regulation (EC) 726/2004 and Articles 31 and 107i of Directive 2001/83/EC. The procedures are also called referrals (we have called them reviews in these questions and answers). If the hearing is postponed and you have been invited as an observer or a speaker, you should tell us as soon as possible if you cannot attend the rearranged hearing. We can then give your place to somebody else who wants to attend. 40. How will the Agency handle my personal information? We protect your personal data and process it according to Regulation (EC) No. 45/2001 the Agency s website says how we process personal data under Privacy statement. More details are also included in the application form. By sending in your application, you declare that you have read and understood the guidelines on personal data, and that you will respect these guidelines if you attend the public hearing. These guidelines are included in the online application form. 13
16 European Medicines Agency 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0) Facsimile +44 (0) Send questions on public hearings to: April 2018 EMA/541085/2016 European Medicines Agency, Reproduction is authorised provided the source is acknowledged.
Update on public hearing
Update on public hearing PCWP/HCPWP joint meeting Presented by Juan Garcia Burgos on 0 September 017 Head of Public Engagement Department An agency of the European Union A public hearing provides An opportunity
More informationGOC Guidance for Witnesses in Fitness to Practise Committee Hearings
GOC Guidance for Witnesses in Fitness to Practise Committee Hearings About us The GOC regulates opticians and optical businesses in the UK. There are currently around 26,000 optometrists, dispensing opticians,
More informationFrequently asked questions
13 February 2017 EMA/527628/2011 Rev. 1 Directorate This document provides answers to the most frequently asked questions received by the European Medicines Agency (EMA).If the answer to your question
More informationGOC GUIDANCE FOR WITNESSES IN FITNESS TO PRACTISE COMMITTEE HEARINGS
GOC GUIDANCE FOR WITNESSES IN FITNESS TO PRACTISE COMMITTEE HEARINGS The purpose of this guidance document The purpose of this guidance is to explain what happens if you are asked by the General Optical
More informationPreparing for an Oral Hearing: Taxi, Limousine or other PDV Applications
Reference Sheet 12 Preparing for an Oral Hearing: Taxi, Limousine or other PDV Applications This Reference Sheet will help you prepare for an oral hearing before the Passenger Transportation Board. You
More informationWhat if someone complains about me? A guide to the complaint process
What if someone complains about me? A guide to the complaint process Introduction The purpose of the licensed building practitioner scheme is to set performance standards for building practitioners and
More informationTeacher misconduct - Information for witnesses
Teacher misconduct - Information for witnesses Providing evidence to Professional Conduct Panel Hearings for the regulation of the teaching profession 1 Contents 1. Introduction 3 2. What is the process
More informationTenant & Service User Involvement Strategy
Tenant & Service User Involvement Strategy Policy No: HM 07 Page: 1 of 9 Tenant & Service User Involvement Strategy 1. Introduction 1.1 Loreburn's Mission Statement is "Delivering Excellence" and we see
More informationSafeguarding adults: mediation and family group conferences: Information for people who use services
Safeguarding adults: mediation and family group conferences: Information for people who use services The Social Care Institute for Excellence (SCIE) was established by Government in 2001 to improve social
More informationImportant Information About Your Hearing
Important Information About Your Hearing The Landlord and Tenant Board The Residential Tenancies Act has rules for landlords and tenants to follow. If one side thinks the other side has not followed these
More informationSOS: Sheltered Outreach Service. Helping older people stay independent and at home
SOS: Sheltered Outreach Service Helping older people stay independent and at home Raven SOS stands for sheltered outreach support. The friendly SOS team, part of Raven Housing Trust, provides a support
More informationAutism Action Network Charter
Autism Action Network Charter Introduction The Autism Action Network is an exciting opportunity for you to be part of a passionate community committed to helping people with autism to live the life they
More informationUCLH Cancer Collaborative Patient Experience and User Involvement Steering Group Member s Role Description: People affected by cancer
UCLH Cancer Collaborative Patient Experience and User Involvement Steering Group Member s Role Description: People affected by cancer This is an opportunity for people affected by cancer to have a significant
More informationADVOCATE PARTICIPANT KIT 2018
ADVOCATE PARTICIPANT KIT 2018 Participant Policy Participants are required to attend the entire program beginning with the opening session on Friday, November 2, 2018. The program will begin at 12:30 pm
More informationADVOCATE PARTICIPANT KIT 2017
ADVOCATE PARTICIPANT KIT 2017 1 P a g e Participant Policy Participants are required to attend the entire program beginning with the opening session on Monday, September 25, 2017. The program will begin
More information#AWP16 Conference & Bookfair Presenters Guidelines
#AWP16 Conference & Bookfair Presenters Guidelines Please read the following information to ensure a successful and wellattended event. All conference events will be held at the Los Angeles Convention
More informationMental capacity and mental illness
Mental capacity and mental illness The Mental Capacity Act 2005 (MCA) Mental capacity is the ability to make your own decisions. If you lose mental capacity the Mental Capacity Act 2005 (MCA) protects
More informationGuidance for Witnesses
Guidance for Witnesses Introduction Giving evidence before the Fitness to Practise Committee of the General Pharmaceutical Council is likely to be unfamiliar to you and can seem to be a daunting process.
More informationOutcome Report on Pilot to involve patients in benefit/risk discussions at CHMP meetings
3 March 2017 EMA/191955/2017 Stakeholders & Communication Division Outcome Report on Pilot to involve patients in benefit/risk discussions at CHMP 1. Background/Rationale A range of mechanisms have been
More informationUK Stroke Assembly North Monday 4 June Tuesday 5 June 2018 Radisson Blu Hotel, Manchester Airport, M90 3RA
Use this booking form if you have aphasia or communication difficulties. If you need help completing this form, contact us on 01527 903 917. UK Stroke Assembly North Monday 4 June Tuesday 5 June 2018 Radisson
More informationHow Clinical Trials Work
A Guide to: How Clinical Trials Work Clinical trials are rigorously controlled tests designed to examine the safety and / or effectiveness of medicines, devices, treatments, or preventive measures in humans.
More informationTHE ISLES OF SCILLY PARENT CARERS GROUP STRUCTURE & ORGANISATION
THE ISLES OF SCILLY PARENT CARERS GROUP STRUCTURE & ORGANISATION We are parent carers of children under the age of 19 who have any additional need. The additional need can be emotional, physical, educational,
More informationAdult ADHD Service Patient Information Leaflet
Adult ADHD Service Patient Information Leaflet Our contact details Adult ADHD Service Keegan Court Grassbanks Gateshead NE10 8DX Tel: 0191 287 6250 Fax: 0191 287 6251 Email: NTAWNT.ANDS@nhs.net Please
More informationMeeting someone with disabilities etiquette
Meeting someone with disabilities etiquette Many people unsure how to go about meeting someone with a disability because they don t want to say or do the wrong thing. Here are a few tips to keep in mind
More informationThe New Mental Health Act A Guide to Named Persons
The New Mental Health Act A Guide to Named Persons The New Mental Health Act A Guide to Named Persons Scottish Executive, Edinburgh 2004 Crown copyright 2004 ISBN: 0-7559-4345-7 Scottish Executive St Andrew
More informationeasy read Your rights under THE accessible InformatioN STandard
easy read Your rights under THE accessible InformatioN STandard Your Rights Under The Accessible Information Standard 2 1 Introduction In July 2015, NHS England published the Accessible Information Standard
More informationHow Ofsted regulate childcare
Information for parents about Ofsted s role in regulating childcare This section provides information about how Ofsted regulates childcare providers. It sets out how you might like to use the information
More informationBarium swallow for adults
Barium swallow for adults Radiology Department Patient information leaflet This leaflet provides you with information about having a barium swallow. It explains what is involved and who you will meet.
More informationDeciding whether a person has the capacity to make a decision the Mental Capacity Act 2005
Deciding whether a person has the capacity to make a decision the Mental Capacity Act 2005 April 2015 Deciding whether a person has the capacity to make a decision the Mental Capacity Act 2005 The RMBI,
More informationFrequently Asked Questions
Frequently Asked Questions These were updated on March 2018. 1. Details of revised Scheme from 4 April 2018 We are retaining the higher level of award ( 1,000) for childminders who care for children with
More informationThe European Medicines Agency (EMA)
The European Medicines Agency (EMA) Nathalie Bere and Maria Mavris Public Engagement Department EMA Training Day 21 November, 2017 An agency of the European Union What is the European Medicines Agency
More informationProcedural advice on publication of information on withdrawals of applications related to the marketing authorisation of human medicinal products
25 June 2013 rev. 1 1. Procedural advice on publication of information on withdrawals of applications related to the marketing authorisation of human 1 Editorial revisions have been made to the table of
More informationInstructor s Guide. Building Healthier Communities. Introduction T
Building Healthier Communities Instructor s Guide Introduction T his instructor s guide is designed to provide you with helpful suggestions collected from a wide range of congregational health programs
More informationArea Organiser s Handbook
National Women s Register Area Organiser s Handbook 23 Vulcan House Vulcan Road North Norwich, NR6 6AQ 01603 406767 office@nwr.org.uk www.nwr.org.uk / www.facebook.com/nwruk / twitter.com/nwruk www.linkedin.com/company/nwr
More informationHow to apply for Access to Work (AtW) online: (Correct as of September 2018)
This is information to help you apply for AtW. It is worth reading all of this before you start applying because it will help you be prepared with your answers, and gives you suggestions about how to explain
More informationPatient and public involvement. Guidance for researchers
Patient and public involvement Guidance for researchers Contents What is patient and public involvement and why is it important? 3 Benefits of patient and public involvement for researchers 4 Levels of
More informationFit, faint or funny turn? Information for people who may have had a first seizure
Fit, faint or funny turn? Information for people who may have had a first seizure page 2 During their lifetime, many people will have a single seizure. Having one seizure does not mean you have epilepsy.
More informationInterpretype Video Remote Interpreting (VRI) Subscription Service White Paper September 2010
Interpretype Video Remote Interpreting (VRI) Subscription Service White Paper September 2010 Overview: Interpretype Video Remote Interpreting (VRI) Subscription Service is a revolutionary method of scheduling,
More informationTips When Meeting A Person Who Has A Disability
Tips When Meeting A Person Who Has A Disability Many people find meeting someone with a disability to be an awkward experience because they are afraid they will say or do the wrong thing; perhaps you are
More informationQ&A on Off-Label Use. EMA Industry Stakeholder Platform - Operation of EU Pharmacovigilance Legislation 12 January 2015
Proposal in response to EFPIA paper of 3 rd October 2014 EMA Industry Stakeholder Platform - Operation of EU Pharmacovigilance Legislation 12 January 2015 Presented by Sabine Brosch (EMA) and Anja van
More informationYour visit to theatre
Your visit to theatre Information for you about your anaesthetic and your visit to the operating theatre This leaflet provides information about coming into hospital for your operation It explains anaesthetic
More informationNAMI California Peer-to-Peer Mentor Training Application
Page 1 of 5 NAMI California Peer-to-Peer Mentor Training Application Date of the training: City where training will be held: Applicant Information: Name: Affiliate: Address: Phone: Email: Cell Phone: Best
More informationGroup Leaders Guidance
Group Leaders Guidance In providing this guidance MKU3A considers it will help with the role of established Group Leaders and provide some written support and information for running the group. If you
More informationCelebrating Young People programme. Lessons Learnt Evaluation
Celebrating Young People programme Lessons Learnt Evaluation June 2013 November 2014 1. Introduction 1.1 The Celebrating Young People programme is a pilot project which supports young people to strengthen
More informationThis document is to be used as reference for the Community Garden Committee should circumstances change, this arrangement will be reviewed.
Governing Relationship with Bankside Open Spaces Trust (BOST) Terms of Reference for the Community Garden Committee at Tate Modern under the Bankside Open Spaces Trust (BOST) Umbrella This document is
More informationUK Stroke Assembly (South)
UK Stroke Assembly (South) Tuesday 15 March 2016, 9am 4pm Monday 3 July Tuesday 4 July 2017 Stirling Radisson Court Blu Stansted, Hotel, Stirling, Stansted Scotland, Airport, Essex, FK9 4LA CM24 1PP Take
More informationUniversity College Hospital. Having an MRI arthrogram. Imaging Department
University College Hospital Having an MRI arthrogram Imaging Department If you would like this leaflet in another format, for example: large print or audio, or in translation please contact us on 020 3456
More informationUniversity College Hospital. Having an MRI defecating proctogram. Imaging Department
University College Hospital Having an MRI defecating proctogram Imaging Department If you would like this leaflet on another format, for example, a large print, or audio, or in translation, please contact
More informationFacilitator Application CA Training
Page 1 of 5 Facilitator Application CA Training Note: Please fill out the application completely. Date of the training: City where training will be held: Contact Information: Last Name: First Name: M.I.:
More informationGP Information Sheet
UK Teratology Information Service Regional Drug & Therapeutic Centre Wolfson Unit Newcastle upon Tyne NE2 4HH Tel: 0191 269 6197 Fax: 0191 260 6193 www.uktis.org GP Information Sheet Influenza A/H1N1v
More informationWorkplace Fundraising Information Pack
Workplace Fundraising Information Pack World Autism Acceptance Day Tuesday 2 April 2019 #hoodieup Thank you! Thank you for being part of World Autism Acceptance Day on Tuesday 2 April 2019. With your support,
More informationIAPP KnowledgeNet Chapter Chair Manual 2018
IAPP KnowledgeNet Chapter Chair Manual 2018 CHAIR ROLES & EXPECTATIONS IAPP RESPONSIBILITIES PLANNING A CHAPTER MEETING INFORMATION & TIPS FOR HOST VENUE INFORMATION & TIPS FOR SPEAKERS OTHER CHAPTER VOLUNTEERS
More informationAdvocacy Program Research Awareness Event Tool Kit for Community Cancer Centers
Advocacy Program Research Awareness Event Tool Kit for Community Cancer Centers Contents Background... 3 Introduction... 3 Research Advocacy Group Planning Meeting... 3 Sample Agenda for Research Advocacy
More informationAustralian Aid Local Media Engagement
Australian Aid Local Media Engagement 1 Your Guide to Influencing Local Media Engaging local media is one of the most effective ways we can help influence public and political opinion in support for a
More informationBSL communication support during pregnancy and birth
BSL communication support during pregnancy and birth Information for patients Maternity Services PROUD TO MAKE A DIFFERENCE SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST page 2 of 12 About this guide
More informationMETROLINX ADMINISTRATIVE FEE DISPUTE RESOLUTION PROCESS RULES OF PRACTICE
METROLINX ADMINISTRATIVE FEE DISPUTE RESOLUTION PROCESS RULES OF PRACTICE Overview The Metrolinx Act, 2006, gives Metrolinx ( Metrolinx ) the authority to establish a system of administrative fees to ensure
More informationPrEP Impact Trial: A Pragmatic Health Technology Assessment of PrEP and Implementation. Part 1
The Elton John Centre Sussex House 1 Abbey Road Brighton BN2 1ES Tel 01273 523079 Fax 01273 523080 PARTICIPANT INFORMATION SHEET AND CONSENT FORM PrEP Impact Trial: A Pragmatic Health Technology Assessment
More informationReferral information for referrals to Bucks Priority Dental Service (Buckinghamshire part of BPDS)
Referral information for referrals to Bucks Priority Dental Service (Buckinghamshire part of BPDS) Referring patients to Special Care Dentistry Services (BPDS) aims is to provide a comprehensive treatment
More informationA study about how parts of the brain work in people with Down syndrome
A study about how parts of the brain work in people with Down syndrome Our names are Carla Startin, Sarah Hamburg and Ros Hithersay. We are researchers working at University College London. We are carrying
More informationSECURING AND UTILISING THE SERVICES OF SIGN LANGUAGE INTERPRETERS FOR THE UNITED NATIONS
SECURING AND UTILISING THE SERVICES OF SIGN LANGUAGE INTERPRETERS FOR THE UNITED NATIONS Updated Version 25 June 2015 Whenever planning international events, all efforts should be made to communicate with
More informationDraft Falls Prevention Strategy
Cheshire West & Chester Council Draft Falls Prevention Strategy 2017-2020 Visit: cheshirewestandchester.gov.uk Visit: cheshirewestandchester.gov.uk 02 Cheshire West and Chester Council Draft Falls Prevention
More informationAccessibility. Serving Clients with Disabilities
Accessibility Serving Clients with Disabilities Did you know that just over 15.5% of Ontarians have a disability? That s 1 in every 7 Ontarians and as the population ages that number will grow. People
More informationPublic Hearing on Valproate
EUROPEAN MEDICINES AGENCY SCI E N C E M E D I C I N E S H ealth Public Hearing on Valproate First experience and lessons learnt Table of contents Introduction... 2 Background... 2 PART A: IMPACT OF PUBLIC
More informationPlease take time to read this document carefully. It forms part of the agreement between you and your counsellor and Insight Counselling.
Informed Consent Please take time to read this document carefully. It forms part of the agreement between you and your counsellor and Insight Counselling. AGREEMENT FOR COUNSELLING SERVICES CONDUCTED BY
More informationOur Pledge to Children in Care and Care Leavers
Our Pledge to Children in Care and Care Leavers 1 Designed and printed by Bristol City Council, Bristol Design OCTOBER 15 BD7047 Bristol Corporate Parenting Strategy The Bristol Pledge The pledge is a
More informationFAQ (Frequently Asked Questions) about Virtual Meetings
FAQ (Frequently Asked Questions) about Virtual Meetings 1) How do I log in to an online meeting? This is similar to asking directions to face-to-face meetings. Different online meetings have different
More informationVersion 1 February Patient and public involvement (PPI) in research groups. Guidance for Chairs
Version 1 February 2010 Patient and public involvement (PPI) in research groups Guidance for Chairs Foreword As a doctor and researcher, I chair a number of research groups which include patients and members
More informationExample documents to help you:
Example documents to help you: Survey Flyer Agenda for your first meeting Minutes for a meeting Equal opportunities statement A model constitution Code of conduct Example survey 1) Would you be interested
More informationa patient s guide Radioiodine therapy for benign (non-cancerous) thyroid disease Patient Information Series PI 14
Nuclear Medicine Department Mount Vernon Hospital Rickmansworth Road Northwood Middlesex HA6 2RN Telephone: 020 3826 2263 Mon - Fri: 8.30am - 4.30pm a patient s guide Radioiodine therapy for benign (non-cancerous)
More informationPeople s Panel today. You can use your views and experiences to help us help other young people.
Aged 16-25? Help us design new advice and support for children and We re Mind, the mental health charity. If you re Aged aged between 16-16 25? and 25, we d Help like you us to apply design to join our
More informationPlanning for a time when you cannot make decisions for yourself
Planning for a time when you cannot make decisions for yourself An information leaflet for members of the public Version: October 2013 Introduction The Mental Capacity Act 2005 allows you to plan ahead
More informationeasy read Your rights under THE accessible InformatioN STandard
easy read Your rights under THE accessible InformatioN STandard Your Rights Under The Accessible Information Standard 2 Introduction In June 2015 NHS introduced the Accessible Information Standard (AIS)
More informationChildminding: Guidance to the National Standards
Childminding: Guidance to the National Standards Revisions to certain criteria: version 2 February 2004 HMI 2089 Crown copyright 2004 Document reference number: HMI 2089 To obtain an additional copy, contact:
More informationMy handbook. Easy English
My handbook Easy English Wellways National Consumer and Carer Advisory Committee 2017 helped write your handbook. Thank you! Wellways Australia Limited 2018 In your handbook We are Wellways...5 Who is
More informationThe European Medicines Agency (EMA)
The European Medicines Agency (EMA) Nathalie Bere Patient Relations Public Engagement Department EMA Training Day 29 November, 2016 An agency of the European Union What is the European Medicines Agency
More informationFrequently Asked Questions
Frequently Asked Questions (Updated November 2018.) The Department for Education has taken the decision to end the Childcare Business Grant Scheme (CBGS) from 31 March 2019. This is based largely on a
More informationWhat happens if I cannot make decisions about my care and treatment?
Information Line: 0800 999 2434 Website: compassionindying.org.uk What happens if I cannot make decisions about my care and treatment? This factsheet explains how decisions are made about your care or
More informationSt Mungo s Community Hosting Guide
St Mungo s Community Hosting Guide This guidance has been put together to help potential Community Host Volunteers think through what is involved when opening their home to an individual and offering them
More informationLABORATORY ANIMAL SCIENCE ASSOCIATION. Information Booklet
LABORATORY ANIMAL SCIENCE ASSOCIATION Information Booklet Platinum Sponsor: Gold Sponsors: Silver Sponsors: Bronze Sponsors: Welcome! We are pleased to invite you to Birmingham for the 2017 LASA Annual
More information107 If I have the proofs DTA wanted, should I still ask for a hearing?
Part 6 Appeal Rights 106 What are my rights if DTA denies, cuts or stops my SNAP? If DTA denies your SNAP benefits or stops or lowers your benefits, you can ask for a fair hearing. A fair hearing, or an
More informationPreliminary Thoughts
Effective meetings Preliminary Thoughts Who likes a meeting Without a clearly defined agenda That seems to drag-on forever That rambles from topic-to-topic That ends without any apparent result? These
More informationEMA confirms recommendations to minimise risk of brain infection PML with Tysabri
25/04/2016 EMA/266665/2016 EMA confirms recommendations to minimise risk of brain infection PML with Tysabri More frequent MRI scans should be considered for patients at higher risk On 25 February 2016,
More informationReview of National Disability Insurance Scheme Decisions Practice Direction
Review of National Disability Insurance Scheme Decisions Practice Direction 1 July 2013 This Practice Direction explains what we will do when we review a decision made by the National Disability Insurance
More informationGood Practice Notes on School Admission Appeals
Good Practice Notes on School Admission Appeals These notes are for supplementary information only and have no statutory basis. Full guidance is available from the Department for Education www.dfe.gov.uk
More informationCHALLENGE EVENT Welcome Pack
CHALLENGE EVENT Welcome Pack Thank you for taking on a challenge! We know it s not easy for anyone to tackle a marathon, climb a mountain or even a Skydive! that s why we think you are amazing for doing
More informationThe Clean Environment Commission. Public Participation in the Environmental Review Process
The Clean Environment Commission Public Participation in the Environmental Review Process Manitoba Clean Environment Commission Who are we? The Manitoba Clean Environment Commission is an arms-length agency
More informationPeer Mentoring Guide for Student Mentees
Peer Mentoring Guide for Student Mentees 2 Contents Welcome and Introduction 3 Frequently Asked Questions 4-5 What Students Say... 6 Guidelines for Mentees 7 Data Protection Both mentors and mentees must
More informationPatient information leaflet. Royal Surrey County Hospital. NHS Foundation Trust. Barium meal. Radiology Department
Patient information leaflet Royal Surrey County Hospital NHS Foundation Trust Barium meal Radiology Department The Barium meal examination You have been referred by your Doctor for a Barium meal examination
More informationGuidelines for Accessible Conferences. A guide by the British Philosophical Association and the Society for Women in Philosophy UK
Guidelines for Accessible Conferences A guide by the British Philosophical Association and the Society for Women in Philosophy UK September 2018 Authorship This document was devised following the SWIP/BPA
More informationThe. What-if? Workbook. How to Make Decisions About Your Mental Health Treatment. Ahead of Time. w i t h a d va n c e d i r e c t i v e s
The What-if? Workbook How to Make Decisions About Your Mental Health Treatment Ahead of Time w i t h a d va n c e d i r e c t i v e s The What-If? Workbook How to Make Decisions About Your Mental Health
More informationParticipant Information Sheet
Appendix A Participant Information Sheet for Young People Participant Information Sheet Exploring experiences of disclosure and non-disclosure amongst young adolescents who hear voices Hi. My name is Rachel
More informationACCESSIBLE CUSTOMER SERVICE: USE OF ASSISTIVE DEVICES BY THE GENERAL PUBLIC
ADMINISTRATIVE PROCEDURE Approval Date 2014 Review Date 2019 Contact Person/Department Superintendent of Specialized Services Replacing All previous policies Page 1 of 5 Identification BD-2082 ACCESSIBLE
More informationFORENSIC HYPNOSIS WITH THE DEAF AND HEARING IMPAIRED
FORENSIC HYPNOSIS WITH THE DEAF AND HEARING IMPAIRED By: Inspector Marx Howell, BS (ret.) Unfortunately, I had not given much thought to the use of hypnosis with a deaf or hearing impaired individual until
More informationHOW TO START AN MPN PATIENT SUPPORT GROUP MPN RESEARCH FOUNDATION
HOW TO START AN MPN PATIENT SUPPORT GROUP MPN RESEARCH FOUNDATION How to begin 1. Find Potential Group Members The first step to take in establishing a support group is to get the word out to MPN patients
More informationUK Teratology Information Service Regional Drug & Therapeutics Centre Wolfson Unit Newcastle upon Tyne NE2 4HH PARTICIPANT INFORMATION SHEET
UK Teratology Information Service Regional Drug & Therapeutics Centre Wolfson Unit Newcastle upon Tyne NE2 4HH Tel: 0191 260 6197 Fax: 0191 260 6193 www.uktis.org PARTICIPANT INFORMATION SHEET Influenza
More informationLevel 1: Hospital name. University College Hospital
Level 1: Hospital name University College Hospital Radiofrequency Ablation (RFA) for the Treatment of Thyroid Nodules Interventional Radiology Imaging Department If you would like this document in another
More informationGood enough? Breast cancer in the UK
Good enough? Breast cancer in the UK Your guide to meeting your MSP Good enough? Breast cancer in the UK Our new report is full of new ideas to make sure that, by 2050, everyone who develops breast cancer
More informationPhysio Essentials For large corporate schemes with 250+ insured employees. Retirement Investments Insurance Health
Physio Essentials For large corporate schemes with 250+ insured employees Retirement Investments Insurance Health Looking after your employees health According to the Centre for Health Economics, back
More informationMedicines in Scotland: What s the right treatment for me? Information for patients and the public
Medicines in Scotland: What s the right treatment for me? Information for patients and the public You can read and download this document from our website. We are happy to consider requests for other languages
More information